In contrast, both exosomes before and after therapy from patients treated with surgery and adjuvant CRT induced a highly mesenchymal profile in recipient tumor cells (classical EMT with reduced E-cadherin and increased vimentin expression) with no difference between the timepoints. This evidence concerns the gene CDH1 and neoplasm.